Effect of dapagliflozin on atherosclerosis and the mechanism related to sodium hydrogen exchanger 1
Author:
Affiliation:

1.Guizhou Medical University, Guiyang 550004, China. 2. Comprehensive Ward, the Affiliated Hospital of Guizhou Medical University, Guiyang 550004. 3. Department of Cardiovascular Medicine, the Affiliated Hospital of Guizhou Medical University, Guiyang 550004

Clc Number:

R-33

Fund Project:

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Objective To investigate the effect of dapagliflozin on the formation of atherosclerosis (AS) in apolipoprotein E knockout (ApoE- / -) mice and the mechanism associated with sodium-hydrogen exchanger 1 (NHE1). Methods 24 6-week-old male ApoE- / - mice were randomly divided into ordinary diet group, high-fat diet group, high-fatdiet+dapagliflozin group (10 mg / (kg·d) gavage) and high-fat diet+glimepiride group (0. 5 mg / ( kg·d) gavage). AS plaques in mouse aorta was observed by using HE staining after 8 weeks. The expression of sodium-glucose cotransporter 2 (SGTL2) in the aorta was measured by quantitative PCR and Western blot. NHE1 expression was detected by immunohistochemistry. Then, mouse macrophage cell line RAW 264. 7 cells were treated with dapagliflozin (10 μmol / L), amiloride (20 μmol / L) and lipopolysaccharide (100 ng / mL) for 24 h. The expression of NHE1 protein was analyzed by Western blot. The recovery rate ( NHE1 activity) from the NH4Cl-induced acid load was assayed by SNARF-1/ AM fluorescence method. TNF-α, IL-1β, IL-6, IL-10 secretion were determined by enzyme-linked immunosorbent assay. Results The AS plaque area in the aorta of the high-fat diet+dapagliflozin group was significantly lower than that of the high-fat diet group (P<0. 05). The expression of SGLT2 in the aortic plaques of each group was significantly decreased (P<0. 05). The plaque NHE1 expression in the high-fat diet+dapagliflozin group was lower than that in the high-fat diet group (P<0. 05). Compared with the LPS group, the LPS+dapagliflozin group had a significantly lower NHE1 protein level in the RAW 264. 7 cells ( P< 0. 05). SNARF-1 fluorescence assay indicated dapagliflozin inhibited NHE1 activity with decreasing intracellular pH (P<0. 05). ELISA showed that the contents of TNF-α, IL-1β and IL-6 in the cell supernatant were significantly decreased, whereas the content of IL-10 was significantly increased ( P< 0. 05 ). Conclusions Dapagliflozin inhibits AS plaque development and cytokine release by inhibiting NHE1 expression and its activity.

    Reference
    Related
    Cited by
Get Citation
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:April 08,2022
  • Revised:
  • Adopted:
  • Online: January 16,2023
  • Published: